Alliancebernstein L.P. Adma Biologics, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 243,470 shares of ADMA stock, worth $4.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,470

Previous 218,370 11.49%

Holding current value

$4.72 Million

Previous $1.44 Million 88.83%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $150,098 - $280,618	25,100 Added 11.49%	243,470 $2.72 Million
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $135,388 - $207,389	30,770 Added 16.4%	218,370 $1.44 Million
Q2 2023 Aug 15, 2023	BUY	$3.12 - $4.22 $238,368 - $322,408	76,400 Added 68.71%	187,600 $692,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $161,044 - $252,976	65,200 Added 141.74%	111,200 $431,000
Q3 2022 Nov 15, 2022	BUY	$2.03 - $2.86 $42,223 - $59,488	20,800 Added 82.54%	46,000 $112,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $36,036 - $55,440	25,200 New	25,200 $50,000
Q2 2021 Jul 30, 2021	SELL	$1.51 - $2.07 $123,820 - $169,740	-82,000 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$1.67 - $2.95 $1,169 - $2,065	-700 Reduced 0.85%	82,000 $144,000
Q4 2020 Feb 08, 2021	SELL	$1.8 - $2.56 $46,440 - $66,048	-25,800 Reduced 23.78%	82,700 $161,000
Q3 2020 Nov 12, 2020	SELL	$2.04 - $3.74 $155,856 - $285,736	-76,400 Reduced 41.32%	108,500 $259,000
Q2 2020 Aug 13, 2020	BUY	$2.42 - $3.29 $228,448 - $310,576	94,400 Added 104.31%	184,900 $542,000
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $100,350 - $307,071	66,900 Added 283.47%	90,500 $261,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $83,072 - $123,664	23,600 New	23,600 $91,000

Others Institutions Holding ADMA

# of Institutions

265

Shares Held

178M

Call Options Held

535K

Put Options Held

21.2K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.81B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Adma Biologics, Inc. Transaction History